DE Burlo Group Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,685 shares of the healthcare conglomerate's stock after selling 850 shares during the quarter. DE Burlo Group Inc.'s holdings in UnitedHealth Group were worth $3,888,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $30,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth about $32,000. 87.86% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
UNH has been the topic of several analyst reports. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating on the stock in a report on Thursday. KeyCorp lowered their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Morgan Stanley lowered their target price on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a report on Tuesday. Three investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Buy" and a consensus price target of $603.05.
Read Our Latest Stock Report on UNH
UnitedHealth Group Stock Performance
NYSE UNH opened at $418.20 on Friday. UnitedHealth Group Incorporated has a 1 year low of $412.02 and a 1 year high of $630.73. The firm has a market cap of $382.53 billion, a price-to-earnings ratio of 26.98, a PEG ratio of 1.37 and a beta of 0.61. The company has a fifty day moving average price of $503.28 and a 200-day moving average price of $535.01. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the firm earned $6.91 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.01%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.